(-)-epigallocatechin 3-gallate multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC6A8 mRNA CTD PMID:22079256 (1->4)-beta-D-glucan multiple interactions ISO Slc6a8 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC6A8 mRNA CTD PMID:36331819 1,2,4-trimethylbenzene decreases expression EXP 6480464 pseudocumene results in decreased expression of SLC6A8 protein CTD PMID:17337753 1,2-dimethylhydrazine decreases expression ISO Slc6a8 (Mus musculus) 6480464 1 and 2-Dimethylhydrazine results in decreased expression of SLC6A8 mRNA CTD PMID:22206623 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of SLC6A8 mRNA CTD PMID:17557909 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Slc6a8 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A8 mRNA CTD PMID:21570461 and PMID:26377647 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of SLC6A8 mRNA CTD PMID:34747641 2,4-dinitrotoluene affects expression EXP 6480464 2 and 4-dinitrotoluene affects the expression of SLC6A8 mRNA CTD PMID:21346803 2,6-dinitrotoluene affects expression EXP 6480464 2 and 6-dinitrotoluene affects the expression of SLC6A8 mRNA CTD PMID:21346803 2-methylcholine affects expression ISO SLC6A8 (Homo sapiens) 6480464 beta-methylcholine affects the expression of SLC6A8 mRNA CTD PMID:21179406 3,4-methylenedioxymethamphetamine increases expression ISO Slc6a8 (Mus musculus) 6480464 N-Methyl-3 and 4-methylenedioxyamphetamine results in increased expression of SLC6A8 mRNA CTD PMID:20188158 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of SLC6A8 mRNA CTD PMID:28522335 4-hydroxyphenyl retinamide increases expression ISO Slc6a8 (Mus musculus) 6480464 Fenretinide results in increased expression of SLC6A8 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine increases expression ISO SLC6A8 (Homo sapiens) 6480464 Decitabine results in increased expression of SLC6A8 mRNA CTD PMID:17908484 6-propyl-2-thiouracil decreases expression EXP 6480464 Propylthiouracil results in decreased expression of SLC6A8 mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of SLC6A8 mRNA CTD PMID:31881176 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of SLC6A8 mRNA CTD PMID:22484513 more ... all-trans-retinoic acid decreases expression ISO Slc6a8 (Mus musculus) 6480464 Tretinoin results in decreased expression of SLC6A8 mRNA CTD PMID:16604517 all-trans-retinoic acid increases expression ISO SLC6A8 (Homo sapiens) 6480464 Tretinoin results in increased expression of SLC6A8 mRNA CTD PMID:33167477 all-trans-retinoic acid increases expression EXP 6480464 Tretinoin results in increased expression of SLC6A8 mRNA CTD PMID:20488242 all-trans-retinoic acid decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Tretinoin results in decreased expression of SLC6A8 mRNA CTD PMID:21934132 ammonia affects expression ISO SLC6A8 (Homo sapiens) 6480464 Ammonia affects the expression of SLC6A8 protein CTD PMID:20227315 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of SLC6A8 mRNA CTD PMID:16483693 ampicillin increases expression ISO SLC6A8 (Homo sapiens) 6480464 Ampicillin results in increased expression of SLC6A8 mRNA CTD PMID:21632981 arsane multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A8 mRNA CTD PMID:32525701 arsenic atom multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A8 mRNA CTD PMID:32525701 arsenous acid increases expression ISO SLC6A8 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SLC6A8 mRNA CTD PMID:20458559 atenolol decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Atenolol results in decreased expression of SLC6A8 mRNA CTD PMID:19915711 benzo[a]pyrene increases expression ISO Slc6a8 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of SLC6A8 mRNA CTD PMID:22228805 benzo[a]pyrene increases methylation ISO SLC6A8 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased methylation of SLC6A8 5' UTR more ... CTD PMID:27901495 benzo[a]pyrene diol epoxide I increases expression ISO SLC6A8 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of SLC6A8 mRNA CTD PMID:25181051 bisphenol A increases expression ISO Slc6a8 (Mus musculus) 6480464 bisphenol A results in increased expression of SLC6A8 mRNA CTD PMID:35479511 bisphenol A affects expression ISO SLC6A8 (Homo sapiens) 6480464 bisphenol A affects the expression of SLC6A8 mRNA CTD PMID:30903817 bisphenol A increases methylation EXP 6480464 bisphenol A results in increased methylation of SLC6A8 gene CTD PMID:28505145 butanal increases expression ISO SLC6A8 (Homo sapiens) 6480464 butyraldehyde results in increased expression of SLC6A8 mRNA CTD PMID:26079696 C60 fullerene increases expression EXP 6480464 fullerene C60 results in increased expression of SLC6A8 mRNA CTD PMID:19167457 cadmium atom multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC6A8 mRNA CTD PMID:35301059 cadmium dichloride multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [Cadmium Chloride results in increased abundance of Cadmium] which results in decreased expression of SLC6A8 mRNA CTD PMID:35301059 caffeine affects phosphorylation ISO SLC6A8 (Homo sapiens) 6480464 Caffeine affects the phosphorylation of SLC6A8 protein CTD PMID:35688186 captan increases expression ISO Slc6a8 (Mus musculus) 6480464 Captan results in increased expression of SLC6A8 mRNA CTD PMID:31558096 carbamazepine affects expression ISO SLC6A8 (Homo sapiens) 6480464 Carbamazepine affects the expression of SLC6A8 mRNA CTD PMID:25979313 carbon nanotube increases expression ISO Slc6a8 (Mus musculus) 6480464 Nanotubes and Carbon results in increased expression of SLC6A8 mRNA CTD PMID:25554681 CGP 52608 multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 CGP 52608 promotes the reaction [RORA protein binds to SLC6A8 gene] CTD PMID:28238834 chlorpyrifos decreases expression EXP 6480464 Chlorpyrifos results in decreased expression of SLC6A8 mRNA CTD PMID:17452286 chlorpyrifos multiple interactions ISO Slc6a8 (Mus musculus) 6480464 Chlorpyrifos promotes the reaction [Hemicholinium 3 binds to SLC6A8 protein] CTD PMID:33007016 chlorpyrifos increases expression EXP 6480464 Chlorpyrifos results in increased expression of SLC6A8 mRNA CTD PMID:18812211 choline multiple interactions ISO Slc6a8 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC6A8 mRNA CTD PMID:20938992 chromium(6+) affects expression ISO Slc6a8 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of SLC6A8 mRNA CTD PMID:28472532 cisplatin multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of SLC6A8 mRNA CTD PMID:21858171 copper atom increases expression EXP 6480464 Copper results in increased expression of SLC6A8 mRNA CTD PMID:30556269 copper(0) increases expression EXP 6480464 Copper results in increased expression of SLC6A8 mRNA CTD PMID:30556269 copper(II) sulfate decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of SLC6A8 mRNA CTD PMID:19549813 cyclosporin A decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of SLC6A8 mRNA CTD PMID:20106945 more ... D-gluconic acid increases expression EXP 6480464 gluconic acid results in increased expression of SLC6A8 mRNA CTD PMID:16556975 diarsenic trioxide increases expression ISO SLC6A8 (Homo sapiens) 6480464 Arsenic Trioxide results in increased expression of SLC6A8 mRNA CTD PMID:20458559 diazinon increases expression EXP 6480464 Diazinon results in increased expression of SLC6A8 mRNA CTD PMID:18812211 dicrotophos increases expression ISO SLC6A8 (Homo sapiens) 6480464 dicrotophos results in increased expression of SLC6A8 mRNA CTD PMID:28302478 dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of SLC6A8 mRNA CTD PMID:18812211 diflunisal increases expression ISO Slc6a8 (Mus musculus) 6480464 Diflunisal results in increased expression of SLC6A8 mRNA CTD PMID:29901742 dioxygen increases expression ISO SLC6A8 (Homo sapiens) 6480464 Oxygen deficiency results in increased expression of SLC6A8 mRNA CTD PMID:20042640 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in decreased expression of SLC6A8 mRNA CTD PMID:33729688 diquat decreases expression ISO Slc6a8 (Mus musculus) 6480464 Diquat results in decreased expression of SLC6A8 protein CTD PMID:36851058 dorsomorphin multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin increases expression ISO SLC6A8 (Homo sapiens) 6480464 Doxorubicin results in increased expression of SLC6A8 mRNA CTD PMID:29803840 elemental selenium increases expression ISO SLC6A8 (Homo sapiens) 6480464 Selenium results in increased expression of SLC6A8 mRNA CTD PMID:19244175 entinostat decreases expression ISO SLC6A8 (Homo sapiens) 6480464 entinostat results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 entinostat multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 epoxiconazole decreases expression ISO Slc6a8 (Mus musculus) 6480464 epoxiconazole results in decreased expression of SLC6A8 mRNA CTD PMID:35436446 folic acid multiple interactions ISO Slc6a8 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC6A8 mRNA CTD PMID:20938992 folpet increases expression ISO Slc6a8 (Mus musculus) 6480464 folpet results in increased expression of SLC6A8 mRNA CTD PMID:31558096 glyphosate increases expression ISO Slc6a8 (Mus musculus) 6480464 Glyphosate results in increased expression of SLC6A8 mRNA CTD PMID:35897073 graphite affects expression EXP 6480464 Graphite affects the expression of SLC6A8 mRNA CTD PMID:29933104 hydrogen peroxide affects expression ISO SLC6A8 (Homo sapiens) 6480464 Hydrogen Peroxide affects the expression of SLC6A8 mRNA CTD PMID:20044591 L-methionine multiple interactions ISO Slc6a8 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of SLC6A8 mRNA CTD PMID:20938992 lead diacetate increases expression EXP 6480464 lead acetate results in increased expression of SLC6A8 mRNA CTD PMID:11578147 mercury dibromide decreases expression ISO SLC6A8 (Homo sapiens) 6480464 mercuric bromide results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 mercury dibromide multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with mercuric bromide co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 methamphetamine increases expression EXP 6480464 Methamphetamine results in increased expression of SLC6A8 mRNA CTD PMID:15644446 methylmercury chloride decreases expression ISO SLC6A8 (Homo sapiens) 6480464 methylmercuric chloride results in decreased expression of SLC6A8 mRNA CTD PMID:28001369 N-ethyl-N-nitrosourea increases mutagenesis EXP 6480464 Ethylnitrosourea results in increased mutagenesis of SLC6A8 gene CTD PMID:16495775 naphthalenes decreases expression EXP 6480464 Naphthalenes results in decreased expression of SLC6A8 protein CTD PMID:17337753 orphenadrine affects expression EXP 6480464 Orphenadrine affects the expression of SLC6A8 mRNA CTD PMID:23665939 ozone increases expression ISO Slc6a8 (Mus musculus) 6480464 Ozone results in increased expression of SLC6A8 mRNA CTD PMID:33026818 p-chloromercuribenzoic acid decreases expression ISO SLC6A8 (Homo sapiens) 6480464 p-Chloromercuribenzoic Acid results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 p-chloromercuribenzoic acid multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with p-Chloromercuribenzoic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 panobinostat multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with Panobinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 panobinostat decreases expression ISO SLC6A8 (Homo sapiens) 6480464 panobinostat results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 paracetamol affects expression ISO Slc6a8 (Mus musculus) 6480464 Acetaminophen affects the expression of SLC6A8 mRNA CTD PMID:17562736 paracetamol increases expression ISO SLC6A8 (Homo sapiens) 6480464 Acetaminophen results in increased expression of SLC6A8 mRNA CTD PMID:29067470 paracetamol decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Acetaminophen results in decreased expression of SLC6A8 mRNA CTD PMID:22230336 PCB138 decreases expression EXP 6480464 2 more ... CTD PMID:23829299 pentanal increases expression ISO SLC6A8 (Homo sapiens) 6480464 pentanal results in increased expression of SLC6A8 mRNA CTD PMID:26079696 perfluorononanoic acid decreases expression ISO SLC6A8 (Homo sapiens) 6480464 perfluoro-n-nonanoic acid results in decreased expression of SLC6A8 mRNA CTD PMID:32588087 perfluorooctane-1-sulfonic acid multiple interactions ISO Slc6a8 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of SLC6A8 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of SLC6A8 mRNA CTD PMID:36331819 phenylmercury acetate decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Phenylmercuric Acetate results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 phenylmercury acetate multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 pirinixic acid decreases expression EXP 6480464 pirinixic acid results in decreased expression of SLC6A8 mRNA CTD PMID:19162173 piroxicam multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [Piroxicam co-treated with Cisplatin] results in increased expression of SLC6A8 mRNA CTD PMID:21858171 potassium chromate increases expression ISO SLC6A8 (Homo sapiens) 6480464 potassium chromate(VI) results in increased expression of SLC6A8 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in increased expression of SLC6A8 mRNA CTD PMID:22079256 propanal increases expression ISO SLC6A8 (Homo sapiens) 6480464 propionaldehyde results in increased expression of SLC6A8 mRNA CTD PMID:26079696 quercetin decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Quercetin results in decreased expression of SLC6A8 mRNA CTD PMID:21632981 resorcinol increases expression ISO SLC6A8 (Homo sapiens) 6480464 resorcinol results in increased expression of SLC6A8 mRNA CTD PMID:22623647 rotenone increases expression EXP 6480464 Rotenone results in increased expression of SLC6A8 mRNA CTD PMID:19013527 and PMID:28374803 SB 431542 multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 selenium atom increases expression ISO SLC6A8 (Homo sapiens) 6480464 Selenium results in increased expression of SLC6A8 mRNA CTD PMID:19244175 silicon dioxide increases expression ISO Slc6a8 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of SLC6A8 mRNA CTD PMID:23221170 and PMID:29203145 sodium arsenate multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [sodium arsenate results in increased abundance of Arsenic] which results in increased expression of SLC6A8 mRNA CTD PMID:32525701 sodium dichromate increases expression ISO Slc6a8 (Mus musculus) 6480464 sodium bichromate results in increased expression of SLC6A8 mRNA CTD PMID:31558096 sunitinib increases expression ISO SLC6A8 (Homo sapiens) 6480464 Sunitinib results in increased expression of SLC6A8 mRNA CTD PMID:31533062 tamoxifen increases expression ISO Slc6a8 (Mus musculus) 6480464 Tamoxifen results in increased expression of SLC6A8 mRNA CTD PMID:25123088 tetrachloromethane affects expression ISO Slc6a8 (Mus musculus) 6480464 Carbon Tetrachloride affects the expression of SLC6A8 mRNA CTD PMID:17484886 tetrachloromethane increases expression ISO Slc6a8 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of SLC6A8 mRNA CTD PMID:31919559 toluene affects expression EXP 6480464 Toluene affects the expression of SLC6A8 mRNA CTD PMID:18653662 trichostatin A decreases expression ISO SLC6A8 (Homo sapiens) 6480464 trichostatin A results in decreased expression of SLC6A8 mRNA CTD PMID:24935251 and PMID:26272509 trichostatin A multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with trichostatin A co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 trimellitic anhydride decreases expression ISO Slc6a8 (Mus musculus) 6480464 trimellitic anhydride results in decreased expression of SLC6A8 mRNA CTD PMID:19042947 urethane increases expression ISO SLC6A8 (Homo sapiens) 6480464 Urethane results in increased expression of SLC6A8 mRNA CTD PMID:28818685 valproic acid affects expression ISO Slc6a8 (Mus musculus) 6480464 Valproic Acid affects the expression of SLC6A8 mRNA CTD PMID:17292431 valproic acid multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 valproic acid decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of SLC6A8 mRNA CTD PMID:23179753 more ... valproic acid increases methylation ISO SLC6A8 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of SLC6A8 gene CTD PMID:29154799 valproic acid increases expression ISO Slc6a8 (Mus musculus) 6480464 Valproic Acid results in increased expression of SLC6A8 mRNA CTD PMID:20546886 valproic acid increases expression ISO SLC6A8 (Homo sapiens) 6480464 Valproic Acid results in increased expression of SLC6A8 mRNA CTD PMID:23179753 vitamin E increases expression ISO SLC6A8 (Homo sapiens) 6480464 Vitamin E results in increased expression of SLC6A8 mRNA CTD PMID:19244175 vorinostat decreases expression ISO SLC6A8 (Homo sapiens) 6480464 vorinostat results in decreased expression of SLC6A8 mRNA CTD PMID:26272509 and PMID:27188386 vorinostat multiple interactions ISO SLC6A8 (Homo sapiens) 6480464 [NOG protein co-treated with Vorinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of SLC6A8 mRNA CTD PMID:27188386 zidovudine decreases expression ISO SLC6A8 (Homo sapiens) 6480464 Zidovudine results in decreased expression of SLC6A8 mRNA CTD PMID:24292225 zoledronic acid decreases expression ISO SLC6A8 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of SLC6A8 mRNA CTD PMID:24714768
